The medication helps signal to your brain to eat less and store less, says Mir Ali, MD, a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California
doi:10.1073/pnas.0305902101
GLP-1 receptor agonists like semaglutide (the active ingredient in Ozempic) primarily regulate blood sugar and appetite through the gut-brain axis, with secondary effects on blood pressure and cardiovascular function
Studies on the effect of supplementation on physical performance in women are lacking, but there is little reason to suspect a gender difference in the response to coenzyme Q 10 supplementation
The Proposed GLP-1 Agonist POP Toxin Redistribution Axis In Short Bioaccumulation of POP chemicals into adipose fat from normal to high exposures GLP-1 agonist drug induces rapid adipose fat burning Rapid lipolysis of adipose fat releases stored POPs into the bloodstream in high amounts, and over prolonged periods of time POPs recirculate bound to lipoproteins and to a lesser extent, albumin With the substantial loss of adipose fat, POP toxins are not adequately bio-transformed, but instead redistributed to other lipid-rich organs, cells and tissues Abstract Research studies on lipophilic, persistent organic pollutants (POPs) such as Dioxin, PCB, PBDEs and HCB have demonstrated that these types of toxins are predominantly stored in adipose fat
Do not expose to sunlight or heat
